Study ID: PM030
Study Title
- A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Teva Identifier
- PM030
ClinicalTrials.gov Identifier
- NCT00856635
Study Status
- Completed
Trial Condition(s)
- Optic Neuritis
Interventions
- Drug: Glatiramer Acetate | Drug: placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 02/01/2009 - 02/01/2011
Phase
- Phase 3
Study Type
Interventional